News

Is it actually hay fever? As cities in the UK have been battling pollen 'bombs', signs your sniffles are one of these common spring viruses
As millions of Brits battle runny noses, croaky coughs and watery eyes, it may be easy to chug an antihistamine, but the ...
Pharmabiz3d
AstraZeneca to showcase innovation in infectious disease protection at ESCMID Global 2025
AstraZeneca to showcase innovation in infectious disease protection at ESCMID Global 2025: Cambridge, UK Thursday, April 10, 2025, 15:00 Hrs [IST] AstraZeneca will share new data ...
Portfolio.hu3d
Proportion of RSV hospital admissions on the rise in Hungary
More than 170,000 people still sought medical help for acute respiratory infection (ARI), including 22,000 with ...
Medscape2d
Comparison of Three Multiplex PCR Assays for the Detection of Respiratory Viral Infections
The qualitative Respiratory Validation Panel Global ... H3 or H5), influenza B virus, RSV-A and -B, adenovirus, hMPV, PIV-1, -2, -3 and −4, coronaviruses 229E, NL63, OC43 and HKU1, picornavirus ...
pharmaphorum4d
AZ agrees $1.1bn deal to buy RSV jab developer Icosavax
Icosavax’s pipeline of respiratory disease vaccines is headed by IVX-A12, a virus-like particle (VLP) shot that targets both RSV and human metapneumovirus (hMPV), two major causes of serious ...
Influenza Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies
Discover the latest drugs and treatment options in the Influenza Pipeline. Dive into DelveInsight's comprehensive report ...
Backer Marianne De Sells 79,712 Shares of Vir Biotechnology, Inc. (NASDAQ:VIR) Stock
CEO Backer Marianne De sold 79,712 shares of Vir Biotechnology stock in a transaction that occurred on Thursday, April 3rd. The shares were sold at an average price of $5.95, for a total value of $474 ...